FORMOSA LABORATORIES, INC.
LIVE

Serial Number

99624270

Owner

FORMOSA LABORATORIES, INC

Attorney

Nicole B. Rackiewicz

First Use Date

Aug 28, 2008

Filing Date

Jan 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

FORMOSA LABORATORIES, INC. Trademark

Serial Number: 99624270

FORMOSA LABORATORIES, INC. is a trademark filed by FORMOSA LABORATORIES, INC on January 30, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

FORMOSA LABORATORIES, INC

No. 36, Heping St., Luzhu Dist.,
Taoyuan City , TW

Entity Type: 99

Trademark Details

Filing Date

January 30, 2026

Registration Date

Not Registered

First Use Anywhere

August 28, 2008

First Use in Commerce

August 28, 2008

Published for Opposition

July 7, 2026

Goods & Services

Vaccines for human use; pharmaceutical preparations for human use for treating skin, metabolic, respiratory, neurological, cardiovascular and oncological diseases; anti-inflammatory and analgesic preparations; general anesthetics; sedatives and hypnotics; stimulants for the central nervous system; cardiovascular and hematopoietic pharmaceutical preparations; antibiotics and antiviral preparations being antivirals and antibiotics; antidotes; medical preparations for weight reduction; nicotine patches for use as aids for smoking cessation; pharmaceutical preparations for treating skin, metabolic, respiratory, neurological, cardiovascular and oncological diseases; cough medicines in the nature of cough treatment preparations; bronchodilators; antidepressants; steroids; immunostimulant preparations in the nature of pharmaceutical preparations for enhancing the body's immune response system; pre-filled syringes containing pharmaceutical preparations, namely, syringes sold filled with pharmaceutical preparations for treating skin, metabolic, respiratory, neurological, cardiovascular and oncological diseases; ophthalmic preparations; diagnostic imaging agents for medical purposes, namely, contrasting agent for ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) diagnostic imaging; vitamin and mineral preparations for medical purposes; active pharmaceutical ingredients sold as a component ingredient of pharmaceutical substances for treatment of skin, metabolic, endocrine, infectious, immunological, autoimmune, hematological, respiratory, neurological, cardiovascular, oncological, gastrointestinal, renal, gynecological, reproductive, inflammatory, pain-related and musculoskeletal diseases and disorders, and for the diagnosis of such diseases and disorders; biological and chemical preparations for medical use for treating skin, metabolic, respiratory, neurological, cardiovascular and oncological diseases; disinfectants for medical purposes; hormonal preparations for medical purposes

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2026 NONP
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 9, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 9, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 9, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 9, 2026 CNEA
ASSIGNED TO EXAMINER
May 28, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 23, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 30, 2026 MAFR
NEW APPLICATION ENTERED
Jan 30, 2026 NWAP